Natalia Sergina

1.6k citations
9 papers · 1.3k indexed · 1 hit paper · h-index 9

Natalia Sergina

9 papers receiving 1.2k citations

Hit Papers

Escape from HER-family tyrosine kinase inhibitor therapy ...7652007202620132019250500750

Peers

Natalia Sergina
Comparison fields: 5 of 85
  • Oncology 866
  • Immunology and Allergy 150
  • Radiology, Nuclear Medicine and Imaging 489
  • Molecular Biology 681
  • Genetics 94
Replace S A Prigent with:
S A Prigent United Kingdom
Márk Barok Finland
Xuewu Zhang China
Maria Sundvall Finland
Kendall D. Carey United States
Jonathan R. Reeves United Kingdom
Brigid C. Browne Ireland
Neil A. O’Brien United States
Dhara N. Amin United States
Judit Anido Spain
Natalia Sergina relative to S A Prigent United Kingdom S A Prigent's profile →
Citations per field
00.5×3.2×
S A Prigent · 1×
Citations per year

Countries citing papers authored by Natalia Sergina

Since Specialization
Citations

This map shows the geographic impact of Natalia Sergina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Sergina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Sergina more than expected).

Fields of papers citing papers by Natalia Sergina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Sergina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Sergina. The network helps show where Natalia Sergina may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Natalia Sergina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Natalia Sergina Line = papers co-authored together Natalia Sergina links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 201244
2 201026
3 2010135
4 2007109
5
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3breakdown →
2007765
6 200521
7 2005124
8 200425
9
The role of transforming growth factor alpha in determining growth factor independence.
200332

About Natalia Sergina

Natalia Sergina is a scholar working on Immunology and Allergy, Oncology and Genetics, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Cell Adhesion Molecules Research (2 papers), TGF-β signaling in diseases (2 papers), Cellular Mechanics and Interactions (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Oncology (866 citations), Immunology and Allergy (150 citations) and Radiology, Nuclear Medicine and Imaging (489 citations). Natalia Sergina has collaborated with scholars based in United States. Frequent co-authors include Mark M. Moasser, Byron Hann, Donghui Wang, Kevan M. Shokat, Jimmy A. Blair, Dhara N. Amin, Deepika Ahuja, Marcin Iwanicki, Hilary E. Beggs and Jill K. Slack‐Davis. Their work appears in journals such as Nature, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026